5/16/24 17:11 | 5/15/24 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 2 | 44 | 7 | D | | | | | | | | | | | | | | |
5/16/23 16:53 | 5/16/23 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 19 | 48 | 59 | D | | | | | | | | | | | | | | |
1/17/23 16:05 | 1/15/23 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 4 | 12 | 40 | D | | | | | | | | | | | | | | |
5/17/22 16:29 | 5/13/22 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 18 | 104 | 35 | D | | | | | | | | | | | | | | |
1/18/22 16:06 | 1/15/22 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 4 | 33 | 17 | D | | | | | | | | | | | | | | |
5/17/21 16:28 | 5/14/21 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 9 | 204 | 13 | D | | | | | | | | | | | | | | |
1/15/21 19:24 | 1/15/21 | INO | Inovio Pharmaceuticals, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Shepard Jay | PA | D | | M.d | 0 | 0.00 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
10/8/19 16:08 | 10/7/19 | ARAV | Aravive, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | TX | DO | P,CEO | S | -27 | 6.82 | 0 | -4 | -5 | 73 | D | | | | | | | | | | | | | | |
5/13/19 18:15 | 5/10/19 | ARAV | Aravive, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | TX | DO | P,CEO | S | -7 | 6.11 | 0 | -1 | -2 | 77 | D | | | | | | | | | | | | | | |
2/5/19 19:53 | 2/1/19 | ARAV | Aravive, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | TX | DO | P,CEO | S | -9 | 4.14 | 0 | -2 | -3 | 82 | D | | | | | | | | | | | | | | |
12/26/18 20:01 | 12/21/18 | ARAV | Aravive, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | TX | DO | P,CEO | S | -11 | 3.22 | 0 | -3 | -4 | 84 | D | | | | | | | | | | | | | | |
12/19/18 19:59 | 12/17/18 | ARAV | Aravive, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | TX | DO | P,CEO | S | -45 | 3.96 | 0 | -11 | -11 | 88 | D | | | | | | | | | | | | | | |
5/23/18 17:42 | 5/22/18 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S | -14 | 1.50 | 0 | -9 | -2 | 593 | D | | | | | | | | | | | | | | |
2/12/18 17:25 | 2/8/18 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S | -26 | 1.80 | 0 | -14 | -2 | 602 | D | | | | | | | | | | | | | | |
2/28/17 19:34 | 2/27/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | M.d | 13 | 2.53 | 4 | 5 | 2 | 214 | D | 13 | 247 | 84 | 73 | 46 | 66 | 44 | 18 | 0 | -8 | -1 | | | |
2/28/17 19:34 | 2/27/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S.d | -124 | 24.00 | 4 | -5 | -2 | 214 | D | 13 | 247 | 84 | 73 | 46 | 66 | 44 | 18 | 0 | -8 | -1 | | | |
2/23/17 20:23 | 2/21/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | M.dm | 40 | 2.53 | 3 | 16 | 8 | 214 | D | 0 | 204 | 49 | 49 | 24 | 40 | 30 | 24 | 6 | 4 | -3 | | | |
2/23/17 20:23 | 2/21/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S.dm | -308 | 19.25 | 3 | -16 | -7 | 214 | D | 0 | 204 | 49 | 49 | 24 | 40 | 30 | 24 | 6 | 4 | -3 | | | |
2/6/17 17:23 | 2/3/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S | -92 | 13.69 | 1 | -7 | -3 | 214 | D | -17 | 46 | 26 | 42 | -7 | -11 | -6 | -1 | -4 | 9 | 45 | 27 | | |
2/2/17 20:12 | 1/31/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | M.dm | 54 | 2.53 | 1 | 21 | 11 | 221 | D | -20 | 38 | 29 | 26 | -6 | -10 | -5 | -2 | 4 | 1 | 56 | 33 | | |
2/2/17 20:12 | 1/31/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S.dm | -333 | 13.77 | 1 | -24 | -10 | 221 | D | -20 | 38 | 29 | 26 | -6 | -10 | -5 | -2 | 4 | 1 | 56 | 33 | | |
1/31/17 20:34 | 1/30/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S.d | -233 | 13.52 | 1 | -17 | -7 | 223 | D | -30 | 17 | 13 | 10 | -2 | -18 | -14 | -14 | -2 | -4 | 58 | 33 | | |
1/31/17 20:34 | 1/30/17 | VSAR | Versartis, Inc. | | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | M.d | 27 | 2.53 | 1 | 11 | 5 | 223 | D | -30 | 17 | 13 | 10 | -2 | -18 | -14 | -14 | -2 | -4 | 58 | 33 | | |
8/24/16 18:22 | 8/22/16 | VSAR | Versartis, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shepard Jay | CA | DO | P,CEO | S | -70 | 12.88 | 1 | -5 | -3 | 155 | D | -32 | 1 | 95 | 44 | 24 | 16 | 3 | 1 | 0 | 4 | 3 | 3 | 64 | |